Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-13-062256
Filing Date
2013-11-15
Accepted
2013-11-15 10:43:39
Documents
7
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v360723_10q-a.htm 10-Q/A 22131
  Complete submission text file 0001144204-13-062256.txt   5441040

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT xtls-20130930.xml EX-101.INS 910819
3 XBRL TAXONOMY EXTENSION SCHEMA xtls-20130930.xsd EX-101.SCH 53136
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtls-20130930_cal.xml EX-101.CAL 62558
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtls-20130930_def.xml EX-101.DEF 244613
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtls-20130930_lab.xml EX-101.LAB 379027
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtls-20130930_pre.xml EX-101.PRE 300693
Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filer) CIK: 0001540145 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q/A | Act: 34 | File No.: 000-54646 | Film No.: 131222803
SIC: 2834 Pharmaceutical Preparations